戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d their in vivo phenotype when placed in the athymic mouse.
2 ut mouse), and absent specific immunity (the athymic mouse), and the appropriate B6,129F2 and C57BL/6
3 B1, derived from a fibrosarcoma formed in an athymic mouse following injection of carcinogen-transfor
4    When grafted beneath the renal capsule of athymic mouse hosts, all of the tumor-derived cell strai
5 e grafted to the renal capsule of adult male athymic mouse hosts.
6 ture-based bioassay (in vitro) as well as an athymic mouse (in vivo) bioassay.
7  rapid clearance from the circulation in the athymic mouse/LS174T xenograft model.
8 s of intraperitoneal ovarian carcinoma in an athymic mouse model demonstrated that a monoclonal antib
9 ne methyl ester for antitumor activity in an athymic mouse model implanted ip with H-ras-transformed
10                                     Using an athymic mouse model of endometriosis, we now report that
11              We confirmed the approach in an athymic mouse model of metastatic human breast cancer by
12                   In the human breast cancer athymic mouse model, 90Y-DOTA-peptide-ChL6 had a high th
13                                       Female athymic mouse MR images were obtained on a 4.7-T MRI dev
14                                          The athymic mouse provides such a permissive growth environm
15 e genistein has not been investigated in the athymic mouse tumor implant model.
16 et tumor cells in vivo was examined using an athymic mouse tumor model.
17 y leads to a complete tumor regression in an athymic mouse tumor xenograft model, it fails to do so i
18 eeks of implantation in muscle pouches of an athymic mouse, whereas explanted particles less than 250
19 varian carcinoma and ascites formation in an athymic mouse xenogeneic transplant model of ovarian can
20 o susceptible to ROPV infection by using the athymic mouse xenograft system and adult immunocompetent
21                                          The athymic mouse xenograft system was used to prepare infec
22  immunized monkeys neutralized HPV-11 in the athymic mouse xenograft system.
23  (cRIA) and for neutralization by use of the athymic mouse xenograft system.
24 JG-136 is active over a wide dosage range in athymic mouse xenografts: on a qd x 5 schedule, the maxi
25  human papillomavirus type 11 (HPV11) in the athymic mouse xenograph neutralization assay and bind HP

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。